| Variables | N | % of N | |
| Age | Mean (SD) | 55.2 (10.4) | |
| Median (IQR) | 56 (49 - 62) | ||
| Min, Max | (31; 73) | ||
| Histological type (recoded) | Papillary serous adenocarcinoma | 23 | 63.9 |
| Adenocarcinoma of unknown primary | 6 | 16.7 | |
| Poorly differentiated carcinoma | 5 | 13.9 | |
| Peritoneal papillary serous carcinoma | 2 | 5.6 | |
| Clinical stage classification (recoded) | IIIC | 28 | 77.8% |
| IVA | 1 | 2.8% | |
| IVB | 7 | 19.4% | |
| Karnofsky index | 100 | 8 | 22.2% |
| 90 | 25 | 69.4% | |
| 80 | 3 | 8.3% | |
| Metastatic site | None | 28 | 77.8% |
| Mediastinal lymphadenopathy | 2 | 5.6% | |
| Liver | 4 | 11.1% | |
| Pleura | 1 | 2.8% | |
| Lung | 1 | 2.8% | |
| Ascites | Yes | 36 | 100% |
| Oligometastatic disease | Yes | 3 | 8% |
| No | 33 | 92% | |
| Concurrent disease | Yes | 28 | 77.8% |
| No | 8 | 22.2% | |
| Hypertension | Yes | 15 | 41.7% |
| No | 21 | 58.3% | |
| Diabetes Mellitus | Yes | 6 | 16.7% |
| No | 30 | 83.3% | |